KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $3.1 billion.

  • Thermo Fisher Scientific's Accounts Payables rose 1972.37% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 1972.37%. This contributed to the annual value of $3.1 billion for FY2024, which is 720.75% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Accounts Payables of $3.1 billion as of Q3 2025, which was up 1972.37% from $3.0 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Accounts Payables registered a high of $3.4 billion during Q4 2022, and its lowest value of $2.1 billion during Q3 2021.
  • For the 5-year period, Thermo Fisher Scientific's Accounts Payables averaged around $2.7 billion, with its median value being $2.6 billion (2024).
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 5148.01% in 2021, then crashed by 1505.47% in 2023.
  • Thermo Fisher Scientific's Accounts Payables (Quarter) stood at $2.9 billion in 2021, then increased by 17.93% to $3.4 billion in 2022, then fell by 15.05% to $2.9 billion in 2023, then grew by 7.21% to $3.1 billion in 2024, then grew by 1.33% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q3 2025, $3.0 billion for Q2 2025, and $3.0 billion during Q1 2025.